Lot 1
No lot description published.
Statuscomplete
AwardedFind a Tender · award
Ravulizumab IV Infusion
BuyerBelfast Health & Social Care Trust
StatusAwarded
DeadlineNot published
ValueValue not published
Published13 Oct 2025
What is being bought
Procurement of Ravulizumab IV Infusion.
Lot details
Comparable-procurement analytics
No usable CPV category has been published, so a comparable market set cannot yet be built.
Procurement strategy & market signals
Framework agreementNot published
Dynamic purchasing systemNot published
Competitive procurementNot published
Recurring requirementNot published
Procurement method rationaleThese are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement.
Rationale classificationssingleSuppliersIntellectualPropertyExclusiveRights
Special regimeNot published
Covered byNot published
Submission policyNot published
Selection criteriaNot published
Risk detailsNot published
Planning & early market engagement
BudgetNot published
No-engagement rationaleNot published
Planning documents0
Planning milestones0
No planning milestones published.
Related procurements
No linked framework, prior procurement or reprocurement published.
Awards
1
Statusactive
SupplierALEXION PHARMA UK LIMITED
Contracts
Ravulizumab IV Infusion
Statusactive
Value£1,200,000
Documents & submission route
- Not published
Source data inventory
Diagnostic view. “Not published” means this current release does not provide a value.
| OCID | ocds-h6vhtk-05a0b7 |
|---|---|
| Latest release ID | 064637-2025 |
| Latest release timestamp | Mon Oct 13 2025 10:00:26 GMT+0000 (Coordinated Universal Time) |
| Source | find-a-tender |
| Official notice URL | Not published |
| Tender status | complete |
| Procurement method | direct |
| Procurement method details | Direct award |
| Main procurement category | Not published |
| Above threshold | Not published |
| Legal basis | 2023/54 |
| Tender period: start | Not published |
| Tender period: end | Not published |
| Expression of interest deadline | Not published |
| Enquiry deadline | Not published |
| Award period: start | Not published |
| Award period: end | Not published |
| Submission method details | Not published |
| Submission languages | Not published |
| Electronic catalogue policy | Not published |
| Total tender value | Not published |
| Tender lots in source | 1 |
| Tender items in source | 0 |
| Tender documents in source | 1 |
| Awards in latest release | 1 |
| Contracts in latest release | 1 |
| Parties in latest release | 2 |
Notice history
| Date | Event | Reference |
|---|---|---|
| 13 Oct 2025 | award, contract | 064637-2025 |
| 24 Sept 2025 | award, contract | 059124-2025 |
| 24 Sept 2025 | award, contract | 059118-2025 |
All source data
Unmodified official OCDS data retained by Tenderline for this procurement process.
Complete current OCDS release JSON
{
"id": "064637-2025",
"tag": [
"award",
"contract"
],
"date": "2025-10-13T11:00:26+01:00",
"ocid": "ocds-h6vhtk-05a0b7",
"buyer": {
"id": "GB-PPON-PLQJ-5727-JCLR",
"name": "Belfast Health & Social Care Trust"
},
"awards": [
{
"id": "1",
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKN",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"status": "active",
"suppliers": [
{
"id": "GB-COH-05970106",
"name": "ALEXION PHARMA UK LIMITED"
}
],
"relatedLots": [
"1"
],
"mainProcurementCategory": "goods"
}
],
"tender": {
"id": "DACPM2025-41",
"lots": [
{
"id": "1",
"status": "complete"
}
],
"title": "Ravulizumab IV Infusion",
"status": "complete",
"documents": [
{
"id": "conflictOfInterest",
"description": "Not published",
"documentType": "conflictOfInterest"
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"description": "Procurement of Ravulizumab IV Infusion.",
"procurementMethod": "direct",
"procurementMethodDetails": "Direct award",
"procurementMethodRationale": "These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement.",
"procurementMethodRationaleClassifications": [
{
"id": "singleSuppliersIntellectualPropertyExclusiveRights"
}
]
},
"parties": [
{
"id": "GB-PPON-PLQJ-5727-JCLR",
"name": "Belfast Health & Social Care Trust",
"roles": [
"buyer"
],
"address": {
"region": "UKN06",
"country": "GB",
"locality": "Belfast",
"postalCode": "BT12 6BA",
"countryName": "United Kingdom",
"streetAddress": "Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital"
},
"details": {
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
},
{
"id": "GB-NIR",
"scheme": "UK_CA_DEVOLVED_REGULATIONS",
"description": "Northern Irish devolved regulations apply"
}
]
},
"identifier": {
"id": "PLQJ-5727-JCLR",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "FinanceProcurement@belfasttrust.hscni.net"
}
},
{
"id": "GB-COH-05970106",
"name": "ALEXION PHARMA UK LIMITED",
"roles": [
"supplier"
],
"address": {
"region": "UKH12",
"country": "GB",
"locality": "Cambridge",
"postalCode": "CB2 0AA",
"countryName": "United Kingdom",
"streetAddress": "1 Francis Crick Avenue"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "05970106",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "UKMarketAccess@alexion.com"
},
"additionalIdentifiers": [
{
"id": "PQTX-1761-VLYY",
"scheme": "GB-PPON"
}
]
}
],
"language": "en",
"contracts": [
{
"id": "1",
"title": "Ravulizumab IV Infusion",
"value": {
"amount": 1200000,
"currency": "GBP",
"amountGross": 1200000
},
"period": {
"endDate": "2027-09-30T23:59:59+01:00",
"startDate": "2025-10-09T00:00:00+01:00"
},
"status": "active",
"awardID": "1",
"documents": [
{
"id": "064637-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/064637-2025",
"format": "text/html",
"noticeType": "UK7",
"description": "Contract details notice on Find a Tender",
"documentType": "contractNotice",
"datePublished": "2025-10-13T11:00:26+01:00"
}
],
"dateSigned": "2025-10-09T00:00:00+01:00",
"aboveThreshold": true,
"noAgreedMetricsRationale": "The contract value is below the relevant threshold for key performance indicators."
}
],
"initiationType": "tender"
}Complete JSON history (3 releases)
13 Oct 2025 · 064637-2025 · award, contract
{
"id": "064637-2025",
"tag": [
"award",
"contract"
],
"date": "2025-10-13T11:00:26+01:00",
"ocid": "ocds-h6vhtk-05a0b7",
"buyer": {
"id": "GB-PPON-PLQJ-5727-JCLR",
"name": "Belfast Health & Social Care Trust"
},
"awards": [
{
"id": "1",
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKN",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"status": "active",
"suppliers": [
{
"id": "GB-COH-05970106",
"name": "ALEXION PHARMA UK LIMITED"
}
],
"relatedLots": [
"1"
],
"mainProcurementCategory": "goods"
}
],
"tender": {
"id": "DACPM2025-41",
"lots": [
{
"id": "1",
"status": "complete"
}
],
"title": "Ravulizumab IV Infusion",
"status": "complete",
"documents": [
{
"id": "conflictOfInterest",
"description": "Not published",
"documentType": "conflictOfInterest"
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"description": "Procurement of Ravulizumab IV Infusion.",
"procurementMethod": "direct",
"procurementMethodDetails": "Direct award",
"procurementMethodRationale": "These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement.",
"procurementMethodRationaleClassifications": [
{
"id": "singleSuppliersIntellectualPropertyExclusiveRights"
}
]
},
"parties": [
{
"id": "GB-PPON-PLQJ-5727-JCLR",
"name": "Belfast Health & Social Care Trust",
"roles": [
"buyer"
],
"address": {
"region": "UKN06",
"country": "GB",
"locality": "Belfast",
"postalCode": "BT12 6BA",
"countryName": "United Kingdom",
"streetAddress": "Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital"
},
"details": {
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
},
{
"id": "GB-NIR",
"scheme": "UK_CA_DEVOLVED_REGULATIONS",
"description": "Northern Irish devolved regulations apply"
}
]
},
"identifier": {
"id": "PLQJ-5727-JCLR",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "FinanceProcurement@belfasttrust.hscni.net"
}
},
{
"id": "GB-COH-05970106",
"name": "ALEXION PHARMA UK LIMITED",
"roles": [
"supplier"
],
"address": {
"region": "UKH12",
"country": "GB",
"locality": "Cambridge",
"postalCode": "CB2 0AA",
"countryName": "United Kingdom",
"streetAddress": "1 Francis Crick Avenue"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "05970106",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "UKMarketAccess@alexion.com"
},
"additionalIdentifiers": [
{
"id": "PQTX-1761-VLYY",
"scheme": "GB-PPON"
}
]
}
],
"language": "en",
"contracts": [
{
"id": "1",
"title": "Ravulizumab IV Infusion",
"value": {
"amount": 1200000,
"currency": "GBP",
"amountGross": 1200000
},
"period": {
"endDate": "2027-09-30T23:59:59+01:00",
"startDate": "2025-10-09T00:00:00+01:00"
},
"status": "active",
"awardID": "1",
"documents": [
{
"id": "064637-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/064637-2025",
"format": "text/html",
"noticeType": "UK7",
"description": "Contract details notice on Find a Tender",
"documentType": "contractNotice",
"datePublished": "2025-10-13T11:00:26+01:00"
}
],
"dateSigned": "2025-10-09T00:00:00+01:00",
"aboveThreshold": true,
"noAgreedMetricsRationale": "The contract value is below the relevant threshold for key performance indicators."
}
],
"initiationType": "tender"
}24 Sept 2025 · 059124-2025 · award, contract
{
"id": "059124-2025",
"tag": [
"award",
"contract"
],
"date": "2025-09-24T10:34:19+01:00",
"ocid": "ocds-h6vhtk-05a0b7",
"buyer": {
"id": "GB-PPON-PLQJ-5727-JCLR",
"name": "Belfast Health & Social Care Trust"
},
"awards": [
{
"id": "1",
"date": "2025-09-24T00:00:00+01:00",
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKN",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"title": "Ravulizumab IV Infusion",
"value": {
"amount": 1200000,
"currency": "GBP",
"amountGross": 1200000
},
"status": "pending",
"documents": [
{
"id": "059124-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/059124-2025",
"format": "text/html",
"noticeType": "UK6",
"description": "Contract award notice on Find a Tender",
"documentType": "awardNotice",
"datePublished": "2025-09-24T10:34:19+01:00"
}
],
"suppliers": [
{
"id": "GB-COH-05970106",
"name": "ALEXION PHARMA UK LIMITED"
}
],
"milestones": [
{
"id": "1",
"type": "futureSignatureDate",
"status": "scheduled",
"dueDate": "2025-10-04T23:59:59+01:00"
}
],
"relatedLots": [
"1"
],
"aboveThreshold": true,
"contractPeriod": {
"endDate": "2027-09-30T23:59:59+01:00",
"startDate": "2025-10-04T00:00:00+01:00"
},
"standstillPeriod": {
"endDate": "2025-10-03T23:59:59+01:00"
},
"mainProcurementCategory": "goods"
}
],
"tender": {
"id": "DACPM2025-41",
"lots": [
{
"id": "1",
"status": "complete"
}
],
"title": "Ravulizumab IV Infusion",
"status": "complete",
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"description": "Procurement of Ravulizumab IV Infusion.",
"procurementMethod": "direct",
"procurementMethodDetails": "Direct award"
},
"parties": [
{
"id": "GB-PPON-PLQJ-5727-JCLR",
"name": "Belfast Health & Social Care Trust",
"roles": [
"buyer"
],
"address": {
"region": "UKN06",
"country": "GB",
"locality": "Belfast",
"postalCode": "BT12 6BA",
"countryName": "United Kingdom",
"streetAddress": "Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital"
},
"details": {
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
},
{
"id": "GB-NIR",
"scheme": "UK_CA_DEVOLVED_REGULATIONS",
"description": "Northern Irish devolved regulations apply"
}
]
},
"identifier": {
"id": "PLQJ-5727-JCLR",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "FinanceProcurement@belfasttrust.hscni.net"
}
},
{
"id": "GB-COH-05970106",
"name": "ALEXION PHARMA UK LIMITED",
"roles": [
"supplier"
],
"address": {
"region": "UKH12",
"country": "GB",
"locality": "Cambridge",
"postalCode": "CB2 0AA",
"countryName": "United Kingdom",
"streetAddress": "1 Francis Crick Avenue"
},
"details": {
"vcse": false,
"scale": "large",
"shelteredWorkshop": false,
"publicServiceMissionOrganization": false
},
"identifier": {
"id": "05970106",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "UKMarketAccess@alexion.com"
},
"additionalIdentifiers": [
{
"id": "PQTX-1761-VLYY",
"scheme": "GB-PPON"
}
]
}
],
"language": "en",
"initiationType": "tender"
}24 Sept 2025 · 059118-2025 · award, contract
{
"id": "059118-2025",
"tag": [
"award",
"contract"
],
"date": "2025-09-24T10:28:32+01:00",
"ocid": "ocds-h6vhtk-05a0b7",
"buyer": {
"id": "GB-PPON-PLQJ-5727-JCLR",
"name": "Belfast Health & Social Care Trust"
},
"awards": [
{
"id": "1",
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryAddresses": [
{
"region": "UKN",
"country": "GB",
"countryName": "United Kingdom"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"title": "Ravulizumab IV Infusion",
"value": {
"amount": 1200000,
"currency": "GBP",
"amountGross": 1200000
},
"status": "pending",
"documents": [
{
"id": "059118-2025",
"url": "https://www.find-tender.service.gov.uk/Notice/059118-2025",
"format": "text/html",
"noticeType": "UK5",
"description": "Transparency notice on Find a Tender",
"documentType": "awardNotice",
"datePublished": "2025-09-24T10:28:32+01:00"
}
],
"suppliers": [
{
"id": "GB-COH-05970106",
"name": "ALEXION PHARMA UK LIMITED"
}
],
"milestones": [
{
"id": "1",
"type": "futureSignatureDate",
"status": "scheduled",
"dueDate": "2025-10-03T23:59:59+01:00"
}
],
"relatedLots": [
"1"
],
"aboveThreshold": true,
"contractPeriod": {
"endDate": "2027-09-30T23:59:59+01:00",
"startDate": "2025-10-03T00:00:00+01:00"
},
"mainProcurementCategory": "goods"
}
],
"tender": {
"id": "DACPM2025-41",
"lots": [
{
"id": "1",
"status": "complete"
}
],
"title": "Ravulizumab IV Infusion",
"status": "complete",
"documents": [
{
"id": "conflictOfInterest",
"description": "Not published",
"documentType": "conflictOfInterest"
}
],
"legalBasis": {
"id": "2023/54",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
"scheme": "UKPGA"
},
"description": "Procurement of Ravulizumab IV Infusion.",
"procurementMethod": "direct",
"procurementMethodDetails": "Direct award",
"procurementMethodRationale": "These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement.",
"procurementMethodRationaleClassifications": [
{
"id": "singleSuppliersIntellectualPropertyExclusiveRights"
}
]
},
"parties": [
{
"id": "GB-PPON-PLQJ-5727-JCLR",
"name": "Belfast Health & Social Care Trust",
"roles": [
"buyer"
],
"address": {
"region": "UKN06",
"country": "GB",
"locality": "Belfast",
"postalCode": "BT12 6BA",
"countryName": "United Kingdom",
"streetAddress": "Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital"
},
"details": {
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
},
{
"id": "GB-NIR",
"scheme": "UK_CA_DEVOLVED_REGULATIONS",
"description": "Northern Irish devolved regulations apply"
}
]
},
"identifier": {
"id": "PLQJ-5727-JCLR",
"scheme": "GB-PPON"
},
"contactPoint": {
"email": "FinanceProcurement@belfasttrust.hscni.net"
}
},
{
"id": "GB-COH-05970106",
"name": "ALEXION PHARMA UK LIMITED",
"roles": [
"supplier"
],
"address": {
"region": "UKH12",
"country": "GB",
"locality": "Cambridge",
"postalCode": "CB2 0AA",
"countryName": "United Kingdom",
"streetAddress": "1 Francis Crick Avenue"
},
"identifier": {
"id": "05970106",
"scheme": "GB-COH"
},
"contactPoint": {
"email": "UKMarketAccess@alexion.com"
},
"additionalIdentifiers": [
{
"id": "PQTX-1761-VLYY",
"scheme": "GB-PPON"
}
]
}
],
"language": "en",
"initiationType": "tender"
}